The test, called PROSTOX, is the first of its kind to use microRNAs to predict toxicity from cancer therapy. It could help prevent the burden of long-term complications by identifying patients most at ...
1d
MedPage Today on MSNComorbidities in Midlife Tied to Cancer RiskComorbidities in midlife were associated with a modestly higher risk of cancer overall and more strongly associated with a ...
The center hosted the symposium to celebrate ... engineering cells in the immune system to fight cancer, she said during the panel. As one of UCLA’s few female engineering faculty, Chen said ...
After the news that Hollywood legend Val Kilmer has died, one man has opened up about his battle with a similar diagnosis of ...
An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the ...
member of the UCLA Health Jonsson Comprehensive Cancer Center, and first author of the study. Partial gland cryoablation freezes and destroys only the cancerous part of the prostate, instead of ...
In his final years, Val Kilmer, who has died at the age of 65, lived with the devastating effects of throat cancer, which ...
A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest evidence yet that a shorter, standard-dose course radiation treatment is just ...
member of the UCLA Health Jonsson Comprehensive Cancer Center, and first author of the study Partial gland cryoablation freezes and destroys only the cancerous part of the prostate, instead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results